BRAF V600E Mutations and Beyond: A Molecular Perspective of Melanoma from a Tertiary Cancer Referral Center of India
Open Access
- 2 March 2023
- journal article
- research article
- Published by Georg Thieme Verlag KG in South Asian Journal of Cancer
- Vol. 12 (04), 359-370
- https://doi.org/10.1055/s-0043-1760759
Abstract
Objectives Malignant melanoma demonstrates frequently occurring mutations of genes in the serine/threonine kinase pathway, namely BRAF, NRAS, and neurofibromin 1. There is rare documentation of a detailed analysis of these mutations in cases of melanoma among Indian patients. We present molecular features in cases of malignant melanoma, diagnosed at a tertiary cancer referral center in India, over a period of 8 years (2011–2018). Materials and Methods This study was performed on formalin fixed paraffin embedded tissues of 88 histologically confirmed cases of malignant melanoma. BRAF gene alterations were studied by both Sanger sequencing and real-time polymerase chain reaction techniques (n = 74). Molecular testing for BRAF and NRAS gene alterations was accomplished in 74/88 cases (80%). Molecular test results were correlated with clinicopathological features using IBM SPSS Statistical software 25.0. Results The age ranged from 13 to 79 years (median = 57), with a M:F ratio of 1.4:1. BRAF mutations were observed in 12/74 (16.21%) patients, including V600E (n = 7), A594T (n = 1), T599 = (n = 2), V600K (n = 1), and Q612P (n = 1), while NRAS mutations were observed in 6/38 (15.7%) patients. Among various subtypes, nodular melanoma was the most frequent subtype (33%) among cutaneous malignant melanomas. Among non-cutaneous melanomas, mucosal melanomas were observed in 37.5% of cases. Conclusion This constitutes one of the few reports on comprehensive analysis of molecular alterations underlying melanomas in Indian patients. A larger sample size, with more extensive molecular markers, would yield additional information on the disease manifestation. Omshree Shetty contributed to conceptualization, methodology, administration. Vaibhavi Vengurlekar helped in data curation, writing-original draft preparation. MamtaGurav contributed to methodology and investigation. Prachi Bapat helped in investigation and supervision. Nupur Karnik contributed to analysis and investigation. Gauri Wagh and Mukta Ramadwar were involved in investigation. Bharat Rekhi and Epari Sridhar reviewed and edited the manuscript. Sangeeta Desai helped in administration and visualization. Article published online: 02 March 2023 © 2023. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, IndiaKeywords
This publication has 41 references indexed in Scilit:
- Immunohistochemical Analysis of BRAFV600E Expression of Primary and Metastatic Melanoma and Comparison With Mutation Status and Melanocyte Differentiation Antigens of Metastatic LesionsThe American Journal of Surgical Pathology, 2013
- Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysisBritish Journal of Dermatology, 2010
- Genetic and morphologic features for melanoma classificationPigment Cell & Melanoma Research, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Malignant melanoma: A retrospective series from a regional cancer center in IndiaJournal of Cancer Research and Therapeutics, 2009
- B-RAF and N-RAS Mutations Are Preserved during Short Time In Vitro Propagation and Differentially Impact PrognosisPLOS ONE, 2007
- NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencingMelanoma Research, 2006
- Cutaneous Melanoma Subtypes Show Different BRAF and NRAS Mutation FrequenciesClinical Cancer Research, 2006
- Analysis of BRAF Mutation in Primary and Metastatic MelanomaCell Cycle, 2005
- International uveal melanoma incidence trends in view of a decreasing proportion of morphological verificationInternational Journal of Cancer, 2004